SGMT
NASDAQ
US
Sagimet Biosciences Inc. - Series A Common Stock
$5.32
▲ +$0.08
(+1.53%)
Vol 159K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$183.5M
ROE
-42.4%
D/E
0.00
Beta
2.75
52W
$2–$11
Wall Street Consensus
18 analysts · Apr 20266
Strong Buy
10
Buy
2
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
CRBP
Corbus Pharmaceuticals Holdings Inc
$142.9M
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
CNTN
Canton Strategic Holdings Inc
CNTB
Connect Biopharma Holdings Ltd
$157.6M
PRLD
Prelude Therapeutics Inc
$164.2M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
Earnings
Beat rate: 75.0%
Next Report
May 11, 2026
EPS Estimate: $-0.36
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.36 | — | — |
| Dec 2025 | $-0.41 | $-0.29 | +$0.12 |
| Sep 2025 | $-0.39 | $-0.40 | $-0.01 |
| Jun 2025 | $-0.52 | $-0.32 | +$0.20 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -39.9% | -22.9% | -22.9% | -22.9% | -42.4% | -42.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 17.55 | 17.55 | 17.55 | 17.55 | 13.06 | 13.06 |
Key Ratios
ROA (TTM)
-40.3%
P/B
0.9
EPS (TTM)
$-1.79
52W High
$11.41
52W Low
$1.73
$1.73
52-Week Range
$11.41
How does SGMT compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
SGMT valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.9
▼
62%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
SGMT profitability vs Biotechnology peers
ROE
-42.4%
▲
37%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-40.3%
▲
14%
above
peers
(-46.7%)
vs Peers
vs Industry
In line
SGMT financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
13.1
▲
194%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.8
▲
183%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
SGMT fundamentals radar
SGMT
Peer median
Industry
SGMT profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SGMT vs peers: key metrics
Latest News
No related news yet